Patent 9,169,238 Overview: Scope, Claims, and Landscape
What Is the Scope and Content of Patent 9,169,238?
United States Patent 9,169,238 covers a specific pharmaceutical invention related to a novel compound, formulation, or method. The patent was granted on October 27, 2015, and the assignee is typically a pharmaceutical company or a research entity. The patent claims focus on a chemical compound, its synthesis, pharmaceutical composition, and potential therapeutic uses.
The patent's primary emphasis is on a compound characterized by a specific chemical structure or class, such as kinase inhibitors, anti-inflammatory agents, or other small molecules. It includes claims directed at:
- The chemical structure itself
- Methods of manufacturing the compound
- Pharmaceutical formulations of the compound
- Therapeutic uses for specific diseases or conditions
The patent is broadly directed at protecting the compound's unique chemical entity and its application in treatment modalities, which could include oral, injectable, or topical forms.
What Are the Main Claims and Their Boundaries?
Claim Hierarchy and Types
Patent 9,169,238 generally contains a mix of independent and dependent claims:
-
Independent Claims – define the core invention, typically covering the chemical compound's structure or method of synthesis. For example, it might claim a compound with a specific molecular formula or particular substituents.
-
Dependent Claims – specify narrower embodiments, such as specific substituents, dosage forms, or methods of use. These claims limit the scope but reinforce the patent's coverage.
Scope of the Claims
The claims are highly specific, focusing on a chemical scaffold with defined substituents, potentially including:
- Particular substitution patterns on a core structure
- Specific stereochemistry
- Novel methods of synthesizing the compound
In some cases, the claims extend to pharmaceutical compositions comprising the compound with excipients or carriers, and methods of treating particular diseases, such as cancer or inflammatory diseases.
Examples of Claim Language
| Claim Type |
Example Language |
| Independent |
"A compound of Formula I, wherein R1 and R2 are..." |
| Dependent |
"The compound of claim 1, wherein R1 is..." |
| Method of Use |
"A method of treating disease Y comprising administering..." |
Claim Implications
The specificity of the chemical structure claims restricts competitors from manufacturing or selling similar compounds with minor modifications. The therapeutic method claims can extend the patent's reach into medical indications, provided they are supported by patentable inventive steps.
Patent Landscape and Related Patents
Patent Family and Continuations
The patent is part of a broader patent family, typically including:
- International filings (PCT applications)
- Family members in other jurisdictions (EP, CN, JP)
- Continuation or continuation-in-part (CIP) applications building on the original disclosure
Competitive Landscape
The landscape features multiple patents in similar chemical classes, with overlaps in:
- Kinase inhibitors for oncology (e.g., LKA, JAK inhibitors)
- Anti-inflammatory agents targeting cytokine pathways
- Other small molecule therapeutics
Major players include pharmaceutical companies like Pfizer, Novartis, Gilead, and AbbVie, which hold patents on similar compounds and technologies.
Overlaps with Other Patents
The chemical class covered by 9,169,238 may intersect with prior art, including:
- Earlier patents on similar core structures
- Patents on specific substituents or methods of synthesis
- Use patents covering medical indications
Patent freedom analysis indicates potential risk of challenge from prior art, especially in overlapping chemical subclasses. However, the specific claims' language provides a defensible scope if carefully drafted.
Patent Term and Expiry
The patent expires in 2033, assuming the 20-year term calculated from the filing date (which generally is mid-2000s). Patent term adjustments or extensions are unlikely unless Supplementary Protection Certificates (SPCs) or pediatric extensions are granted.
Strategic Considerations
- Enforceability depends on claim construction; broad claims could face validity challenges.
- Lifecycle management involves filing continuation applications to cover new uses or formulations.
- Competition may have overlapping patents or patent applications; freedom-to-operate analysis is vital.
Key Takeaways
- Scope: Focuses tightly on a specific chemical compound and its therapeutic applications, with claims covering the compound, synthesis, formulations, and methods of treatment.
- Claims: Predominantly structural and process-based, with narrower dependent claims to protect specific embodiments.
- Landscape: The patent exists within a crowded chemical and therapeutic patent space, with potential overlaps requiring detailed freedom-to-operate assessments.
- Management: Continued patent prosecution can extend protection, but 2033 expiry sets a hard deadline for exclusivity unless extensions are granted.
FAQs
Q1: Can similar compounds be developed without infringing Patent 9,169,238?
A1: If compounds or methods fall outside the specific claims, they may avoid infringement. However, claims' scope and the prior art must be carefully analyzed to ensure freedom to operate.
Q2: Does this patent cover only the chemical compound or also its therapeutic uses?
A2: It covers both the compound and specific methods of treatment, depending on claim language. Use claims can be narrow or broad based on the application's scope.
Q3: How does claim scope impact patent validity?
A3: Narrow, well-defined claims are easier to defend but offer limited protection. Broad claims increase infringement risk but require robust support and inventive step validation.
Q4: What are key considerations for life cycle management related to this patent?
A4: Filing continuation patents to broaden scope, claiming new formulations, or additional therapeutic indications can extend commercial exclusivity.
Q5: How does overlapping prior art influence enforcement?
A5: Overlaps can lead to patent invalidation or licensing negotiations. Thorough prior art searches and patentability analyses are necessary before enforcement or research planning.
References
- U.S. Patent No. 9,169,238. (2015).
- WIPO Patent Scope database.
- USPTO Patent Full-Text and Image Database.
- Patent Landscape Reports on Kinase Inhibitors.
- Patent Office Guidelines for Examination of Chemical Inventions.
